MONECO Advisors LLC Acquires 4,877 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MONECO Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 128.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,687 shares of the healthcare conglomerate’s stock after acquiring an additional 4,877 shares during the period. UnitedHealth Group accounts for 0.9% of MONECO Advisors LLC’s portfolio, making the stock its 23rd largest holding. MONECO Advisors LLC’s holdings in UnitedHealth Group were worth $4,573,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Bray Capital Advisors raised its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after purchasing an additional 50 shares during the period. Bridge Advisory LLC increased its holdings in UnitedHealth Group by 12.8% in the 3rd quarter. Bridge Advisory LLC now owns 662 shares of the healthcare conglomerate’s stock valued at $334,000 after acquiring an additional 75 shares during the last quarter. Valeo Financial Advisors LLC increased its holdings in UnitedHealth Group by 20.5% in the 3rd quarter. Valeo Financial Advisors LLC now owns 14,018 shares of the healthcare conglomerate’s stock valued at $7,068,000 after acquiring an additional 2,382 shares during the last quarter. Mason & Associates Inc increased its holdings in UnitedHealth Group by 8.4% in the 3rd quarter. Mason & Associates Inc now owns 3,263 shares of the healthcare conglomerate’s stock valued at $1,645,000 after acquiring an additional 252 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. increased its holdings in UnitedHealth Group by 1.5% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 8,735 shares of the healthcare conglomerate’s stock valued at $4,404,000 after acquiring an additional 129 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on UNH shares. TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research note on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $5.33 during mid-day trading on Tuesday, reaching $483.70. The company’s stock had a trading volume of 3,366,904 shares, compared to its average volume of 4,466,545. The stock has a 50-day moving average of $485.19 and a two-hundred day moving average of $513.81. The stock has a market capitalization of $445.04 billion, a P/E ratio of 29.63, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the business earned $6.26 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.